Caitong International Asset Management’s Tourmaline Bio TRML Stock Holding History

Caitong International Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,234	Closed	-$59K	–	2375
2025 Q3	$59K	Buy	1,234 +944	+326%	+$26.2K	0.04%	275
2025 Q2	$4.64K	Buy	290 +169	+140%	+$2.74K	﹤0.01%	1048
2025 Q1	$1.84K	Buy	+121	New	+$1.94K	﹤0.01%	1383

Caitong International Asset Management's TRML Position: Q4 2025 in Review

Caitong International Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 1,234 shares — an estimated $59K sold.

Caitong International Asset Management first reported a position in TRML in Q1 2025 and held it in 3 quarters. The position peaked at $59K in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Caitong International Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Caitong International Asset Management sold 1,234 Tourmaline Bio shares in Q4 2025, an estimated $59K.
Caitong International Asset Management first reported a position in Tourmaline Bio in Q1 2025 and held it in 3 quarters.
Caitong International Asset Management's Tourmaline Bio position peaked at $59K in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Caitong International Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.